SELEXEL has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are DONALD CARLTON D, AMPLIPHI BIOSCIENCES CORP and INST OF GENE AND BRAIN SCIENCE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | France | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Syringes | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Brooks Hilary | 11 |
#2 | Cabon Florence | 11 |
#3 | Chusseau Maud | 11 |
#4 | Delmas Stephanie | 6 |
#5 | Delmas Stéphanie | 5 |
Publication | Filing date | Title |
---|---|---|
CN110114076A | New ds oligonucleotides for treating cancer | |
CA3041624A1 | Use of a sirna for treating cancer |